Alzheimer’s Research UK is committing nearly £300,000 (~€341,000) for a landmark phase II clinical trial of Sativex®, a cannabis -based medicine … Read More
The post Cannabis -based medicine to be tested in Azheimer’s trial appeared first on Dagga Magazine.